• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MYX

MAYNE PHARMA GROUP LIMITED - Charts / Financials

1.78% ! $4.58
Market Cap $370.4M  !
Healthcare Drug Manufacturers - Specialty & Generic
Add to My Watchlist

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

refresh Created with Sketch. REFRESH
Last update - 11.08am 11/09/2025 (20 minute delay) ?
Day
Open $4.50   Day High $4.59   Day Low $4.50
Daily Volume 67038
Bids   Sellers
Number Price Volume   Number Price Volume
2 $4.56 550   9 $4.58 2245

Directors & Senior Management

Mr. Shawn Patrick O' Brien Chief Executive Officer, Managing Director, Executive Director
Mr. Aaron Gray Chief Financial Officer
Ms. Laura Loftus Company Secretary
Mr. Frank C. Condella Non-Executive Independent Chairman of the Board
Mr. David Petrie Non-Executive Director
Mr. Patrick J. Blake Independent Non-Executive Director
Ms. Ann Custin Independent Non-Executive Director
Ms. Anne Nicole Lockwood Independent Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$4.58 		Change
0.080(1.78%) 		Mkt cap ! $370.4M
Open High Low Value Volume
$4.50 $4.59 $4.50 $306.3K 67.03K

Buyers (Bids)

No. Vol. Price($)
2 550 $4.56
 

Sellers (Offers)

Price($) Vol. No.
$4.58 2245 9
View Market Depth
Last trade - 11.11am 11/09/2025 (20 minute delay) ?
Last
$4.56 		  Change
0.080 ( 1.25 %)
Open High Low Volume
$4.54 $4.59 $4.54 14869
Last updated 11.08am 11/09/2025 ?

Top Stories

From the 4DS Memory playbook: Boss Energy flags strategic review to sate Honeymoon concerns

Boss Energy's era of vicissitudes could be over as the company has now done what some shareholders have been asking - share some clarity.
Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner In this HotCopper Wire Week 37 episode, we take a look at the Coles and Woolies legal fight and compare 4DMedical and 4DS Memory.
EVR opens strong with funding, acquisition, and sales agreement announcements EVR has caught attention on the HotCopper forums and across the wider Australian markets today with a flurry of announcements.
Red Mountain the latest to join critical minerals rush in Utah with 87 claims Red Mountain Mining has expanded its U.S. critical minerals portfolio, buying up 87 claims in the state's Antimony Mining District.
EV Resources snaps up Nevada antimony project; will raise $5.5M for it, Los Lirios EV Resources has come out of its halt with a bang, unveiling the acquisition of the Dollar Antimony Project in Nye County alongside a raise.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.